|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02219 CHAOJU EYE CARE
Nominal 
2.700 +0.120 (+4.651%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 1,405,454 | 1,369,505 | 990,044 | 997,787 |
| Cost of Sales | -- | -- | (794,152) | (748,371) | (555,347) | (549,113) |
| Gross Profit | -- | -- | 611,302 | 621,134 | 434,697 | 448,674 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (2,028) | (5,835) | (3,957) | (13,608) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | 262,723 | 299,242 | 239,138 | 210,582 | |
| Taxation | -- | -- | (76,513) | (78,507) | (55,942) | (52,941) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 8,866 | 8,179 | 4,556 | 4,108 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 183,445 | -5.962% | 195,076 | 228,914 | 187,752 | 161,749 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | (28,930) | (29,085) | (11,077) | 2,218 |
| Depreciation & Amortisation | -- | -- | 144,161 | 123,361 | 99,366 | 83,522 |
| Directors' Emoluments | -- | -- | 6,664 | 6,013 | 4,323 | 5,161 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 26.000 | -7.143% | 28.000 | 33.000 | 27.000 | 26.000 |
| DPS (cts) | 21.394 | -- | 23.074 | 26.984 | 15.227 | 8.478 |
| Dividend Payout Ratio (%) | 82.284% | -- | 82.405% | 81.770% | 56.396% | 32.609% |
| Cash flow per share ($) | -- | -- | 0.514 | 0.536 | 0.387 | 0.399 |
| NBV per share ($) | -- | -- | 3.272 | 3.335 | 3.212 | 2.976 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 183,445 |
| %Change | -5.962% |
| EPS / (LPS) | RMB 0.260 |
| NBV Per Share (¥) | RMB -- |